2Eggermont AM, Schadendorf D. Melanoma and immunotherapy[J]. Hematol Oncol Clin North Am, 2009, 23(3): 547-564, ix-x.
3Livingstone E, Zimmer L, Vaubel J, et al. Current advances and perspectives in the treatment of advanced melanoma[J]. J Dtsch Dermatol Ges, 2012, 10(5): 319-325.
4Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification [J]. J Clin On- col, 2009, 27(36): 6199-6206.
5Dudley ME, Yang JC, Sherry R, et al. Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens[J]. J Clin On- col, 2008, 26(32): 5233-5239.
6Li Y, Liu S, Hemandez J, et al. MART-l-specific melanoma tu-mor-infiltrating lymphocytes maintaining CD28 expression have improved survival and expansion capability following anti- genic restimulation in vitro[J]. J Immunol, 2010, 184(1): 452- 465.
8Lipson E J, Drake CG. Ipilimumab: an anti-CTLA-4 antibody for metastatic melanoma[J]. Clin Cancer Res, 2011, 17(22): 6958- 6962.
9Hodi FS, O'Day SJ, McDermott DF, et al. Improved survival with ipilimumab in patients with metastatic melanoma[J]. N Engl J Med, 2010, 363(8): 711-723.
10Robert C, Thomas L, Bondarenko I, et al. Ipilimumab plus dacar- bazine for previously untreated metastatic melanoma[J]. N Engl J Med, 2011, 364(26): 2517-2526.
3Batch CM,Gershenwald JE,Soong SJ,et at.Final version of 2009 AJCC melanoma staging and classification.J Clin Oncol,2009,27(36):6199-6206.
4Eggermont AM,Schadendorf D.Melanoma and immunotherapy.Hematol Oncol Clin North Am,2009,23(3):547-564.
5Van der BP,Traversari C,Chomez P,et al.A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.Science,1991,254(5038):1643-1647.
6Nguyen LT,Yen PH,Nie J,et al.Expansion and characterization of human melanoma tumor-infiltrating lymphocytes (TILs).PLoS One,2010,5(11):e13940.
7Rosenberg SA,Restifo NP,Dudley ME,et al.Adoptive cell transfer; a clinical path to effective cancer immunotherapy.Nat Rev Cancer,2008,8(4):299-308.
8Rosenberg SA,Packard BS,Aebersold PM et al.Use of tumor-in-filtrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma.A preliminary report.N Engl J Med,1988,319(25):1676-1680.
9Rosenberg SA,Yannelli JR,Yang JC,et al.Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2.J Natl Cancer Inst,1994,86 (15):1159-1166.
10Rosenberg SA,Restifo NP,Yang JC,et al.Adoptive cell transfer:a clinical path to effective cancer immunotherapy.Nat Rev Cancer.,2008,8(4):299-308.
